Trial Profile
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Efficacy of YSPSL for Prevention of Delayed Graft Function in Patients Undergoing Cadaveric Kidney Transplantation
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 04 Jun 2014
Price :
$35
*
At a glance
- Drugs YSPSL (Primary)
- Indications Delayed graft function
- Focus Therapeutic Use
- Sponsors Ys Therapeutics
- 04 Jun 2014 New trial record